POLYMORPHISMS OF HPC2/ELAC2 AND SRD5A2 (5α-Reductase Type II) GENES IN PROSTATE CANCER

被引：3
|
作者：
Izmirli, M. [1 ]
Arikan, B. [2 ]
Bayazit, Y. [3 ]
Alptekin, D. [4 ]
机构：
[1] Bezmialem Vakif Univ, Dept Med Biol, Fac Med, TR-34093 Istanbul, Turkey
[2] Cukurova Univ, Dept Mol Biol, Fac Sci, Adana, Turkey
[3] Cukurova Univ, Dept Urol, Fac Med, Adana, Turkey
[4] Cukurova Univ, Dept Med Biol, Fac Med, Adana, Turkey
来源：
BALKAN JOURNAL OF MEDICAL GENETICS | 2011年 / 14卷 / 01期
关键词：
Prostate cancer; HPC2/ELAC2; gene; SRD5A2; Polymorphism; RISK; ASSOCIATION; VARIANTS; HEREDITARY; ONSET; CYP17;
D O I：
10.2478/v10034-011-0015-2
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Prostate cancer is the proliferation of malignant cells in the prostate gland. The HPC2/ELAC2 gene on chromosome 17p11.2 and SRD5A2 gene on chromosome 2p22-23 are predisposing genetic factors. We examined the relationship between Ser217Leu and Ala541Thr polymorphisms of the former gene, and Ala49Thr and Val89Leu polymorphisms of the latter gene to prostate cancer in Turkish men, using the polymerase chain reaction (PCR) method and appropriate restriction enzymes. The HPC2/ELAC2 gene Ser217Leu and SRD5A2 gene Ala49Thr polymorphisms were associated with an increased risk of prostate cancer in Turkish men [ for the HPC2/ELAC2 gene Ser217Leu polymorphism: odds ratio (OR) 2.7; confidence interval 95% (CI 95%) 1.6-4.8; p 0.000<0.05, and for the SRD5A2 gene Ala49Thr polymorphism: OR 2.4; CI 95% 1.2-4.9; p 0.004<0.05].
引用
收藏
页码：31 / 35
页数：5
相关论文
共 50 条
  • [21] Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JKV
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (04) : 246 - 253
  • [22] The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population EDITORIAL COMMENT
    Yun, Seok Joong
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (01) : 29 - 30
  • [23] Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer
    Wu, YQ
    Chen, H
    Rubin, MA
    Wojno, KJ
    Cooney, KA
    CANCER RESEARCH, 2001, 61 (24) : 8651 - 8653
  • [24] Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case–control series
    H. Fujiwara
    M. Emi
    H. Nagai
    T. Nishimura
    N. Konishi
    Y. Kubota
    T. Ichikawa
    S. Takahashi
    T. Shuin
    T. Habuchi
    O. Ogawa
    K. Inoue
    M. H. Skolnick
    J. Swensen
    N. J. Camp
    S. V. Tavtigian
    Journal of Human Genetics, 2002, 47 : 641 - 648
  • [25] Evidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients
    Margiotti, K
    Sangiuolo, F
    De Luca, A
    Froio, F
    Pearce, CL
    Ricci-Barbini, V
    Micali, F
    Bonafè, M
    Franceschi, C
    Dallapiccola, B
    Novelli, G
    Reichardt, JKV
    DISEASE MARKERS, 2000, 16 (3-4) : 147 - 150
  • [26] Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series
    Fujiwara, H
    Emi, M
    Nagai, H
    Nishimura, T
    Konishi, N
    Kubota, Y
    Ichikawa, T
    Takahashi, S
    Shuin, T
    Habuchi, T
    Ogawa, O
    Inoue, K
    Solnick, MH
    Swensen, J
    Camp, NJ
    Tavtigian, SV
    JOURNAL OF HUMAN GENETICS, 2002, 47 (12) : 641 - 648
  • [27] Association among polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population
    Paz-y-Mino, Cesar
    Witte, Tania
    Robles, Paulo
    Llumipanta, William
    Diaz, Myriam
    Arevalo, Melissa
    CANCER GENETICS AND CYTOGENETICS, 2009, 189 (02) : 71 - 76
  • [28] Association of 5-alpha-reductase gene (SRD5A2) with prostate cancer.
    Mononen, N
    Koivisto, PA
    Ikonen, T
    Syrjäkoski, K
    Schleutker, J
    Hyytinen, E
    Tammela, TLJ
    Kallioniemi, OP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 95 - 95
  • [29] The genetic polymorphisms of HPC/ELAC2 and HER-2 gene associate with Japanese sporadic prostate cancer
    Yokomizo, A
    Koga, H
    Okumura, K
    Konomoto, T
    Tsukamoto, T
    Hirao, Y
    Akaza, H
    Naito, S
    JOURNAL OF UROLOGY, 2004, 171 (04): : 114 - 114
  • [30] SRD5A2 gene polymorphisms and the risk of prostate cancer:: A meta-analysis
    Ntais, C
    Polycarpou, A
    Ioannidis, JPA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (07) : 618 - 624
12345